Inlyta (axitinib) Approved For Advanced Kidney Cancer, USA - Medical News Today PDF Print

Inlyta (axitinib) Approved For Advanced Kidney Cancer, USA
Medical News Today
The US FDA has approved Inlyta (axitinib) for the treatment of advanced renal cell carcinoma, a type of kidney cancer, in patients with whom other drugs have not been effective, the FDA (Food and Drug Administration) announced today.

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.